These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 17330230

  • 1. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines.
    Howells LM, Mitra A, Manson MM.
    Int J Cancer; 2007 Jul 01; 121(1):175-83. PubMed ID: 17330230
    [Abstract] [Full Text] [Related]

  • 2. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A, Matthes N, Mühling B, Koospal M, Quenzer A, Peter S, Germer CT, Linnebacher M, Otto C.
    Neoplasia; 2017 Apr 01; 19(4):301-309. PubMed ID: 28284059
    [Abstract] [Full Text] [Related]

  • 3. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo.
    Howells LM, Sale S, Sriramareddy SN, Irving GR, Jones DJ, Ottley CJ, Pearson DG, Mann CD, Manson MM, Berry DP, Gescher A, Steward WP, Brown K.
    Int J Cancer; 2011 Jul 15; 129(2):476-86. PubMed ID: 20839263
    [Abstract] [Full Text] [Related]

  • 4. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ, Lee YJ, Hsu TS, Chen WS.
    Chem Biol Interact; 2009 Dec 10; 182(2-3):173-82. PubMed ID: 19735649
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A, Bystrup S, Ruiz de Porras V, Guardia C, Musulén E, Martínez-Cardús A, Manzano JL, Layos L, Abad A, Martínez-Balibrea E.
    PLoS One; 2015 Dec 10; 10(5):e0123830. PubMed ID: 25955657
    [Abstract] [Full Text] [Related]

  • 7. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
    Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, Yasui M, Fujie Y, Matsuzaki T, Hemmi H, Xu X, Kitani K, Seki Y, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Mol Cancer Ther; 2005 Oct 10; 4(10):1585-94. PubMed ID: 16227409
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.
    Arango D, Wilson AJ, Shi Q, Corner GA, Arañes MJ, Nicholas C, Lesser M, Mariadason JM, Augenlicht LH.
    Br J Cancer; 2004 Nov 29; 91(11):1931-46. PubMed ID: 15545975
    [Abstract] [Full Text] [Related]

  • 9. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
    Hayward RL, Macpherson JS, Cummings J, Monia BP, Smyth JF, Jodrell DI.
    Mol Cancer Ther; 2004 Feb 29; 3(2):169-78. PubMed ID: 14985457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
    Li L, Ahmed B, Mehta K, Kurzrock R.
    Mol Cancer Ther; 2007 Apr 29; 6(4):1276-82. PubMed ID: 17431105
    [Abstract] [Full Text] [Related]

  • 12. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
    Atallah D, Marsaud V, Radanyi C, Kornprobst M, Rouzier R, Elias D, Renoir JM.
    Int J Hyperthermia; 2004 Jun 29; 20(4):405-19. PubMed ID: 15204521
    [Abstract] [Full Text] [Related]

  • 13. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S, Epifano F, Preziuso F, Slater J, Nangia-Makker P, Majumdar APN, Fiorito S.
    Biochem Biophys Res Commun; 2020 Jan 29; 522(1):95-99. PubMed ID: 31740005
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines.
    Sheikh BY, Sarker MMR, Kamarudin MNA, Mohan G.
    Biomed Pharmacother; 2017 Dec 29; 96():834-846. PubMed ID: 29078261
    [Abstract] [Full Text] [Related]

  • 15. Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Inducing Gastric Cancer Cell Apoptosis Both In Vitro and In Vivo.
    Zhou X, Wang W, Li P, Zheng Z, Tu Y, Zhang Y, You T.
    Oncol Res; 2016 Jan 21; 23(1-2):29-34. PubMed ID: 26802648
    [Abstract] [Full Text] [Related]

  • 16. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG.
    Cancer Res; 2005 Oct 01; 65(19):8951-60. PubMed ID: 16204068
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.
    Montopoli M, Ragazzi E, Froldi G, Caparrotta L.
    Cell Prolif; 2009 Apr 01; 42(2):195-206. PubMed ID: 19236381
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
    Fiore D, Proto MC, Pisanti S, Picardi P, Pagano Zottola AC, Butini S, Gemma S, Casagni A, Laezza C, Vitale M, Ligresti A, Di Marzo V, Zisterer DM, Nathwani S, Williams DC, Campiani G, Gazzerro P, Bifulco M.
    Cancer Biol Ther; 2016 Aug 02; 17(8):849-58. PubMed ID: 26392056
    [Abstract] [Full Text] [Related]

  • 20. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells.
    Jang CH, Moon N, Oh J, Kim JS.
    Nutrients; 2019 Apr 02; 11(4):. PubMed ID: 30987009
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.